Patents Assigned to Milanapharm LLC
  • Patent number: 10383833
    Abstract: The present invention provides topical dosages and formulations of lidocaine and pharmaceutically acceptable salts thereof, which are efficacious, chemically stable and physiologically balanced for safety and efficacy, particularly for debridement pain, and increase the duration of pain relief, and thereby provide more effective treatment to chronic open wounds, particularly those in non-mucosal tissue.
    Type: Grant
    Filed: October 9, 2017
    Date of Patent: August 20, 2019
    Assignee: Milanapharm LLC
    Inventors: Hemant H Alur, James A H Harwick